Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to -$841128.0.

  • HeartSciences' Net Cash Flow fell 19240.56% to -$841128.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$2.1 million, marking a year-over-year decrease of 15316.37%. This contributed to the annual value of -$4.7 million for FY2025, which is 21356.03% down from last year.
  • As of Q4 2025, HeartSciences' Net Cash Flow stood at -$841128.0, which was down 19240.56% from $1.7 million recorded in Q3 2025.
  • HeartSciences' Net Cash Flow's 5-year high stood at $7.0 million during Q1 2024, with a 5-year trough of -$1.5 million in Q2 2025.
  • In the last 5 years, HeartSciences' Net Cash Flow had a median value of -$742772.0 in 2021 and averaged $5287.8.
  • Within the past 5 years, the most significant YoY rise in HeartSciences' Net Cash Flow was 70928.1% (2024), while the steepest drop was 36910.14% (2024).
  • HeartSciences' Net Cash Flow (Quarter) stood at -$768053.0 in 2021, then crashed by 55.79% to -$1.2 million in 2022, then soared by 60.26% to -$475510.0 in 2023, then surged by 39.51% to -$287658.0 in 2024, then tumbled by 192.41% to -$841128.0 in 2025.
  • Its Net Cash Flow was -$841128.0 in Q4 2025, compared to $1.7 million in Q3 2025 and -$1.5 million in Q2 2025.